Literature DB >> 31018243

Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remission.

Berit Jordan1,2, Stephan Zierz1, Thomas Weber3, Karin Jordan3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31018243     DOI: 10.1002/mus.26495

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  2 in total

1.  Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders.

Authors:  Andrea Antonuzzo; Fabio Calabrò; Pietro Quaglino; Fausto Roila; Gian Domenico Sebastiani; Francesco Spina; Giuseppe Pasqualetti; Diego Cortinovis; Enrico Tagliaferri; Alessandro Peri; Elena Margherita Presotto; Maria Francesca Egidi; Luca Giacomelli; Ferruccio Farroni; Massimo Di Maio; Emmanuele De Luca; Marco Danova; Florian Scottè; Karin Jordan; Paolo Bossi
Journal:  Oncologist       Date:  2020-03-17

2.  Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis.

Authors:  Akiko Ishii; Minato Yokoyama; Hiroshi Tsuji; Yasuhisa Fujii; Akira Tamaoka
Journal:  eNeurologicalSci       Date:  2020-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.